[go: up one dir, main page]

ATE510552T1 - Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors - Google Patents

Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors

Info

Publication number
ATE510552T1
ATE510552T1 AT97929783T AT97929783T ATE510552T1 AT E510552 T1 ATE510552 T1 AT E510552T1 AT 97929783 T AT97929783 T AT 97929783T AT 97929783 T AT97929783 T AT 97929783T AT E510552 T1 ATE510552 T1 AT E510552T1
Authority
AT
Austria
Prior art keywords
thyrotropine
receptor
human
producing secreted
short variants
Prior art date
Application number
AT97929783T
Other languages
English (en)
Inventor
Basil Rapoport
Sandra Mclachlan
Original Assignee
Basil Rapoport
Sandra Mclachlan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basil Rapoport, Sandra Mclachlan filed Critical Basil Rapoport
Application granted granted Critical
Publication of ATE510552T1 publication Critical patent/ATE510552T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97929783T 1996-06-05 1997-06-05 Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors ATE510552T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1917196P 1996-06-05 1996-06-05
PCT/US1997/009624 WO1997046206A2 (en) 1996-06-05 1997-06-05 Human thyrotropin receptor compositions and use thereof

Publications (1)

Publication Number Publication Date
ATE510552T1 true ATE510552T1 (de) 2011-06-15

Family

ID=21791804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97929783T ATE510552T1 (de) 1996-06-05 1997-06-05 Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors

Country Status (6)

Country Link
EP (1) EP0959896B1 (de)
JP (1) JP2000512280A (de)
AT (1) ATE510552T1 (de)
AU (1) AU3376297A (de)
CA (1) CA2258720A1 (de)
WO (1) WO1997046206A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1196430T3 (da) * 1999-06-29 2012-05-21 Mannkind Corp Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AU2002231353A1 (en) * 2000-10-26 2002-05-06 Deltagen, Inc. Knockout mice thyroid stimulating hormone receptor (tsh-r) gene
AU2003220125B2 (en) 2002-03-20 2006-06-15 Mannkind Corporation Inhalation apparatus
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
AU2005277041B2 (en) 2004-08-23 2012-03-22 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
MX381952B (es) 2005-09-14 2025-03-13 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
EP2497484A3 (de) 2006-02-22 2012-11-07 MannKind Corporation Verfahren zur Verbesserung der pharmazeutischen Eigenschaften von Mikropartikeln mit Diketopiperazin und einem Wirkstoff
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
KR101672684B1 (ko) 2008-06-13 2016-11-03 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN103751892B (zh) 2008-06-20 2017-03-01 曼金德公司 用于对吸入工作进行实时描绘的交互式设备和方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
MY186975A (en) 2009-06-12 2021-08-26 Mannkind Corp Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
RU2569776C2 (ru) 2011-04-01 2015-11-27 Маннкайнд Корпорейшн Блистерная упаковка для фармацевтических картриджей
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
RU2650035C2 (ru) 2012-07-12 2018-04-06 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
WO2014186402A1 (en) 2013-05-14 2014-11-20 Siemens Healthcare Diagnostics Inc. Stabilized liquid formulations containing receptors
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (de) 2013-08-05 2020-10-07 MannKind Corporation Insufflationsvorrichtung
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008726A1 (en) * 1990-11-15 1992-05-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Rat thyrotropin receptor gene and uses thereof

Also Published As

Publication number Publication date
AU3376297A (en) 1998-01-05
JP2000512280A (ja) 2000-09-19
EP0959896A2 (de) 1999-12-01
EP0959896A4 (de) 2005-03-02
EP0959896B1 (de) 2011-05-25
WO1997046206A2 (en) 1997-12-11
CA2258720A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
NO951138D0 (no) Mikropartikkelpreparater fremstilt fra biologisk nedbrytbare blandingspolymerer
ATE234124T1 (de) Verfahren zur herstellung von wirkstoffhaltigen knochenzementen
DE69506668D1 (de) Vorrichtung zur herstellung von weichen tissueprodukten
ATE231724T1 (de) Kombinationstherapie für die behandlung von psychosen
ATE185971T1 (de) Kombinationspräparat zur behandlung hypogonadaler männer sowie männern mit hypophysenerkrankungen
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
DE69327659D1 (de) Therapeutische und diagnostische bilderzeugungzusammensetzung und verfahren zur herstellung
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69730224D1 (de) Verfahren und instrument zur untersuchung des herzens und der arterien
DE69717259D1 (de) Dienkautschuk, verfahren zur herstellung des kautschuks und kautschukzusammensetzung die diesen enthält
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69626311D1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69737067D1 (de) Vakzine zur behandlung von mycosen
HK1025793A1 (en) Hepatitis c receptor protein cd81
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
ATA232687A (de) Zahnpflegemittel, sowie verfahren zur herstellung des zahnpflegemittels
DE69734464D1 (de) Verfahren zur expression und herstellung von rekombinantem, menschlichem beta-cis-interferon
DE69709655D1 (de) Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties